Meet the 2016 Class
The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.
For more information about the 2016 class visit the scholars directory.
Biomedical Programs Bolster Promising Early-Career Scientists
June 07, 2016
Over the last 30 years, Pew’s biomedical programs have supported more than 800 innovative, early-career researchers who are working to advance human health. More than just providing financial support, the programs give scientists the opportunity to learn from a network of established researchers through collaboration and mentorship.
In this video, scholars and fellows describe how the mentorship component of Pew’s biomedical programs has fostered their research and professional development.
Learn more about the Pew’s investments in biomedical researchers: http://www.pewtrusts.org/en/projects/biomedical-research.
Our WorkView All
Charles Rice, Ph.D., a molecular virologist at Rockefeller University and 1986 Pew biomedical scholar, will receive the 2016 Lasker-DeBakey Clinical Medical Research Award on Sept. 23 for his role in finding an effective treatment for hepatitis C, an infectious disease that afflicts more than 130 million people worldwide and contributes to 700,000 deaths annually. Rice devised a system to grow... Read More
Pew’s biomedical scholars and fellows are on the cutting edge of biomedical research—using new tools and techniques to tackle complex questions about human health. Every day, they look closely at the molecules and cells that make up our bodies and surroundings. Could you identify their objects of study? Take this quiz to view some of their subjects up close, and see if you can guess what they are. Read More
Arvin Dar, a 2014 Pew-Stewart scholar for cancer research at the Icahn School of Medicine at Mount Sinai, has discovered that a little-known protein—the kinase suppressor of Ras (KSR)—might be the key to a new kind of cancer therapy. Read More